Si-man Ieong
TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Evolution of neutralizing antibodies and cross-activity against different variants of SARS-CoV-2 in patients recovering from COVID-19.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: September 12, 2022
Correlation of adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: August 01, 2022
Immunogenicity and safety of third-dose mRNA COVID-19 vaccines in healthy adults previously vaccinated with two doses of the ChAdOx1 vaccine.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: May 31, 2022
Safety and antibody response of recipients who unexpectedly received undiluted prime dose of BNT162b2 COVID-19 vaccine in Taiwan.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: May 19, 2022
Serological response after COVID-19 mRNA-1273 booster dose in immunocompromised patients, Taiwan, July to August 2021.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: April 05, 2022
Serological response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 prime-boost vaccination with a twelve-week interval.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: March 09, 2022
Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: February 04, 2022
A siRNA targets and inhibits a broad range of SARS-CoV-2 infections including Delta variant.
Journal: EMBO molecular medicine
Published: October 18, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026